|
US20080070981A1
(en)
|
2000-02-23 |
2008-03-20 |
Henryk Borowy-Borowski |
Water-soluble compositions of bioactive lipophilic compounds
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
|
EP1368458A2
(en)
|
2001-02-26 |
2003-12-10 |
Pharma Pacific Pty. Ltd. |
Interferon-alpha induced gene
|
|
ES2350687T3
(es)
|
2002-07-03 |
2011-01-26 |
Ono Pharmaceutical Co., Ltd. |
Composiciones de inmunopotenciación.
|
|
CN1753912B
(zh)
|
2002-12-23 |
2011-11-02 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US7563869B2
(en)
|
2003-01-23 |
2009-07-21 |
Ono Pharmaceutical Co., Ltd. |
Substance specific to human PD-1
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
US8367065B2
(en)
|
2006-09-15 |
2013-02-05 |
Enzon Pharmaceuticals, Inc. |
Targeted polymeric prodrugs containing multifunctional linkers
|
|
HRP20131167T1
(hr)
|
2007-06-18 |
2014-01-03 |
Merck Sharp & Dohme B.V. |
Antitijela za humani receptor programirane smrti pd-1
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
WO2009097128A1
(en)
|
2008-01-29 |
2009-08-06 |
Ludwig Institute For Cancer Research Ltd. |
Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
|
|
WO2009114335A2
(en)
|
2008-03-12 |
2009-09-17 |
Merck & Co., Inc. |
Pd-1 binding proteins
|
|
WO2010098788A2
(en)
|
2008-08-25 |
2010-09-02 |
Amplimmune, Inc. |
Pd-i antagonists and methods for treating infectious disease
|
|
KR101814408B1
(ko)
|
2008-09-26 |
2018-01-04 |
다나-파버 캔서 인스티튜트 인크. |
인간 항-ｐｄ-１, ｐｄ-ｌ１, 및 ｐｄ-ｌ2 항체 및 그의 용도
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
JP6238459B2
(ja)
|
2011-08-01 |
2017-11-29 |
ジェネンテック， インコーポレイテッド |
Ｐｄ−１軸結合アンタゴニストとｍｅｋ阻害剤を使用する癌の治療方法
|
|
EP2908818A4
(en)
|
2012-10-16 |
2016-07-13 |
Endocyte Inc |
CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE
|
|
PL2931738T3
(pl)
|
2012-12-13 |
2019-07-31 |
Aduro Biotech, Inc. |
Kompozycje zawierające cykliczne dinukleotydy purynowe o zdefiniowanej stereochemii i sposoby ich otrzymywania i zastosowania
|
|
RS59500B1
(sr)
|
2013-05-18 |
2019-12-31 |
Aduro Biotech Inc |
Sastavi i metode za aktiviranje signaliziranja koje je zavisno od „stimulatora gena za interferon“
|
|
EP2996472B1
(en)
|
2013-05-18 |
2019-03-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
ES2826398T3
(es)
|
2013-10-15 |
2021-05-18 |
Seagen Inc |
Enlazadores-fármacos pegilados para una mejor farmacocinética de los conjugados ligando-fármaco
|
|
RU2692563C2
(ru)
*
|
2014-04-25 |
2019-06-25 |
Пьер Фабр Медикамент |
Конъюгат антитела против igf-1r с лекарственным средством и его применение для лечения рака
|
|
PE20170198A1
(es)
|
2014-06-04 |
2017-04-08 |
Glaxosmithkline Ip Dev Ltd |
Dinucleotidos ciclicos como moduladores de sting
|
|
TWI695011B
(zh)
|
2014-06-18 |
2020-06-01 |
美商梅爾莎納醫療公司 |
抗ｈｅｒ２表位之單株抗體及其使用之方法
|
|
EP3546473B1
(en)
|
2014-12-16 |
2025-12-10 |
Kayla Therapeutics |
Fluorinated cyclic [(2',5')p(3',5')p]-dinucleotides for cytokine induction
|
|
WO2016096577A1
(en)
|
2014-12-16 |
2016-06-23 |
Invivogen |
Combined use of a chemotherapeutic agent and a cyclic dinucleotide for cancer treatment
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
CR20180101A
(es)
|
2015-08-13 |
2018-04-12 |
Merck Sharp & Dohme |
Compuestos di-nucleóticos cíclicos como agonistas de sting
|
|
CA3002236A1
(en)
|
2015-10-28 |
2017-05-04 |
Aduro Biotech, Inc. |
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
|
|
TWI704154B
(zh)
|
2015-12-03 |
2020-09-11 |
英商葛蘭素史克智慧財產發展有限公司 |
新穎化合物
|
|
US20170158772A1
(en)
*
|
2015-12-07 |
2017-06-08 |
Opi Vi - Ip Holdco Llc |
Compositions of antibody construct - agonist conjugates and methods of use thereof
|
|
EP3386536A4
(en)
|
2015-12-07 |
2019-07-31 |
Opi Vi- IP Holdco LLC |
COMPOSITION OF ANTIBODY CONSTRUCT AGONIST CONJUGATES AND METHOD FOR USE THEREOF
|
|
CN109310885B
(zh)
|
2016-03-15 |
2022-05-31 |
梅尔莎纳医疗公司 |
NaPi2b靶向抗体-药物缀合物及其使用方法
|
|
JP2019510802A
(ja)
|
2016-04-07 |
2019-04-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
タンパク質調節物質として有用な複素環アミド
|
|
HRP20220936T1
(hr)
|
2016-04-07 |
2022-10-28 |
Glaxosmithkline Intellectual Property Development Limited |
Heterociklički amidi korisni kao modulatori proteina
|
|
US10225009B2
(en)
|
2016-07-01 |
2019-03-05 |
Adtran, Inc. |
Broadband access devices having a radio link
|
|
WO2018009466A1
(en)
|
2016-07-05 |
2018-01-11 |
Aduro Biotech, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
|
US10414747B2
(en)
|
2016-10-04 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene compounds as sting agonists
|
|
US11135307B2
(en)
*
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
WO2018140831A2
(en)
|
2017-01-27 |
2018-08-02 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
|
TW201834697A
(zh)
*
|
2017-02-28 |
2018-10-01 |
美商梅爾莎納醫療公司 |
Her2標靶抗體－藥物結合物之組合療法
|
|
AR113224A1
(es)
*
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
Conjugados de anticuerpo que comprenden un agonista de sting
|
|
EP3634401A1
(en)
|
2017-06-07 |
2020-04-15 |
Silverback Therapeutics, Inc. |
Antibody construct conjugates
|
|
US11312772B2
(en)
|
2017-08-04 |
2022-04-26 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and benzo [b] thiophene STING agonists for cancer treatment
|
|
US11285131B2
(en)
|
2017-08-04 |
2022-03-29 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene STING agonists for cancer treatment
|
|
EP3685166A2
(en)
|
2017-09-20 |
2020-07-29 |
Mersana Therapeutics, Inc. |
Compositions and methods for predicting response to napi2b-targeted therapy
|
|
CA3077337A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting)
|
|
US20210238172A1
(en)
|
2017-10-05 |
2021-08-05 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides useful as protein modulators and methods of using the same
|
|
CN111194214A
(zh)
*
|
2017-10-05 |
2020-05-22 |
葛兰素史密斯克莱知识产权发展有限公司 |
施用sting激动剂的方法
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
MX2020004691A
(es)
|
2017-11-07 |
2020-08-20 |
Regeneron Pharma |
Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
|
|
CN110016025B
(zh)
|
2018-01-08 |
2021-08-06 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
|
WO2019134707A1
(zh)
|
2018-01-08 |
2019-07-11 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
|
US11702430B2
(en)
|
2018-04-03 |
2023-07-18 |
Merck Sharp & Dohme Llc |
Aza-benzothiophene compounds as STING agonists
|
|
US10793557B2
(en)
|
2018-04-03 |
2020-10-06 |
Merck Sharp & Dohme Corp. |
Sting agonist compounds
|
|
ES2929415T3
(es)
|
2018-05-25 |
2022-11-29 |
Incyte Corp |
Compuestos heterocíclicos tricíclicos como activadores de STING
|
|
CA3101640A1
(en)
|
2018-06-04 |
2019-12-12 |
Trustees Of Tufts College |
Tumor microenvironment-activated drug-binder conjugates, and uses related thereto
|
|
WO2019243825A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Small molecule modulators of human sting, conjugates and therapeutic applications
|
|
JP2021530442A
(ja)
|
2018-06-28 |
2021-11-11 |
ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co., Ltd. |
縮合三環系複素環化合物およびその治療上の使用
|
|
WO2020010451A1
(en)
*
|
2018-07-10 |
2020-01-16 |
Trillium Therapeutics Inc. |
Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonists
|
|
US10875872B2
(en)
|
2018-07-31 |
2020-12-29 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
JP7584802B2
(ja)
|
2018-08-24 |
2024-11-18 |
アドライ・ノーティ・バイオファーマ・カンパニー・リミテッド |
高活性ｓｔｉｎｇタンパク質アゴニスト
|
|
CN111655682B
(zh)
|
2018-08-29 |
2024-05-31 |
杭州阿诺生物医药科技有限公司 |
一种高活性sting蛋白激动剂化合物
|
|
US20200113912A1
(en)
|
2018-09-12 |
2020-04-16 |
Silverback Therapeutics, Inc. |
Methods and Compositions for the Treatment of Disease with Immune Stimulatory Conjugates
|
|
CN110963997A
(zh)
|
2018-09-28 |
2020-04-07 |
四川科伦博泰生物医药股份有限公司 |
杂环酰胺类化合物、包含其的药物组合物及其制备方法和用途
|
|
BR112021009578A2
(pt)
|
2018-12-06 |
2021-08-17 |
Glaxosmithkline Intellectual Property Development Limited |
formulação farmacêutica
|
|
WO2020132549A1
(en)
|
2018-12-21 |
2020-06-25 |
Nimbus Titan, Inc. |
Sting heterocycle agonists and uses thereof
|
|
WO2020132566A1
(en)
|
2018-12-21 |
2020-06-25 |
Nimbus Titan, Inc. |
Sting pyrazole agonists and uses thereof
|
|
WO2020132582A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Nimbus Titan, Inc. |
Sting agonists and uses thereof
|
|
CN111393405B
(zh)
|
2019-01-02 |
2022-11-25 |
中国科学院上海药物研究所 |
一类含氟取代的苯并噻吩类化合物及其药物组合物及应用
|
|
CN111393404B
(zh)
|
2019-01-02 |
2023-02-17 |
中国科学院上海药物研究所 |
一类苯并噻吩类化合物及其药物组合物及应用
|
|
US12129267B2
(en)
|
2019-01-07 |
2024-10-29 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
CN111471056B
(zh)
|
2019-01-23 |
2021-07-02 |
成都先导药物开发股份有限公司 |
一种大环类免疫调节剂
|
|
EP3919488B1
(en)
|
2019-01-31 |
2025-08-27 |
Hitgen Inc. |
Immunomodulator
|
|
PE20220166A1
(es)
|
2019-03-05 |
2022-01-28 |
F Star Therapeutics Inc |
Compuestos, composiciones y metodos para el tratamiento de enfermedad
|
|
JP7530380B2
(ja)
|
2019-03-28 |
2024-08-07 |
ルピン・リミテッド |
Ｓｔｉｎｇアゴニストとしての大環状化合物
|
|
TW202104214A
(zh)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
化合物
|
|
JP2022529183A
(ja)
|
2019-04-17 |
2022-06-17 |
アヴィディア テクノロジーズ， インコーポレイテッド |
リガンド提示および／または薬物送達のためのスターポリマーを製造する組成物および方法
|
|
CN111848573B
(zh)
|
2019-04-30 |
2023-04-07 |
四川科伦博泰生物医药股份有限公司 |
苯并噻吩酰胺类化合物及其制备方法和用途
|
|
EP3964504A4
(en)
|
2019-04-30 |
2022-12-28 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
AMINOPYRIMIDINE COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
|
WO2020227159A2
(en)
|
2019-05-03 |
2020-11-12 |
Flagship Pioneering Innovations V, Inc. |
Methods of modulating immune activity
|
|
WO2021000770A1
(zh)
|
2019-07-02 |
2021-01-07 |
凯复制药有限公司 |
可增强免疫活性的杂环化合物、其制备方法及其在医药上的应用
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
LT4004002T
(lt)
|
2019-07-22 |
2024-10-25 |
Lupin Limited |
Makrocikliniai junginiai kaip sting agonistai ir jų naudojimo būdai bei metodai
|
|
US20220267364A1
(en)
|
2019-07-25 |
2022-08-25 |
Shanghai Jemincare Pharmaceuticals Co., Ltd. |
Heterocyclic amide compound, preparation method therefor and use thereof
|
|
CA3149482A1
(en)
|
2019-08-02 |
2021-02-11 |
Mersana Therapeutics, Inc. |
Bis-[n-((5-carbamoyl)-1h-benzo[d]imidazol-2-yl)-pyrazol-5-carboxamide] derivatives and related compounds as sting (stimulator of interferon genes) agonists for the treatment of cancer
|
|
WO2021113679A1
(en)
|
2019-12-06 |
2021-06-10 |
Mersana Therapeutics, Inc. |
Dimeric compounds as sting agonists
|
|
CN113248475B
(zh)
|
2020-02-11 |
2023-03-17 |
中国科学院上海药物研究所 |
一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
|
|
WO2021202984A1
(en)
|
2020-04-02 |
2021-10-07 |
Mersana Therapeutics, Inc. |
Antibody drug conjugates comprising sting agonists
|
|
JP2024501894A
(ja)
|
2021-01-04 |
2024-01-16 |
メルサナ セラピューティクス インコーポレイテッド |
Ｂ７ｈ４ターゲティング抗体－薬物コンジュゲートおよびその使用方法
|
|
CN112898286A
(zh)
|
2021-01-28 |
2021-06-04 |
中国药科大学 |
苯并噻吩类化合物或其可药用的盐、异构体及其制备方法、药物组合物和用途
|
|
MX2024010916A
(es)
|
2022-03-07 |
2024-09-17 |
Mersana Therapeutics Inc |
Conjugados anticuerpo-farmaco que comprenden agonistas de sting, combinaciones y metodos de uso.
|